High-dose biotin restores redox balance, energy and lipid homeostasis, and axonal health in a model of adrenoleukodystrophy.


Journal

Brain pathology (Zurich, Switzerland)
ISSN: 1750-3639
Titre abrégé: Brain Pathol
Pays: Switzerland
ID NLM: 9216781

Informations de publication

Date de publication:
09 2020
Historique:
received: 28 02 2020
revised: 24 05 2020
accepted: 26 05 2020
pubmed: 9 6 2020
medline: 17 8 2021
entrez: 9 6 2020
Statut: ppublish

Résumé

Biotin is an essential cofactor for carboxylases that regulates the energy metabolism. Recently, high-dose pharmaceutical-grade biotin (MD1003) was shown to improve clinical parameters in a subset of patients with chronic progressive multiple sclerosis. To gain insight into the mechanisms of action, we investigated the efficacy of high-dose biotin in a genetic model of chronic axonopathy caused by oxidative damage and bioenergetic failure, the Abcd1

Identifiants

pubmed: 32511826
doi: 10.1111/bpa.12869
pmc: PMC8018149
doi:

Substances chimiques

ATP Binding Cassette Transporter, Subfamily D, Member 1 0
Abcd1 protein, mouse 0
Lipids 0
Srebf1 protein, mouse 0
Sterol Regulatory Element Binding Protein 1 0
Biotin 6SO6U10H04
Mechanistic Target of Rapamycin Complex 1 EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

945-963

Subventions

Organisme : CIBERER
Pays : International
Organisme : Instituto de Salud Carlos III
ID : CPII16/00016
Pays : International
Organisme : Instituto de Salud Carlos III
ID : PI17/00916
Pays : International
Organisme : Agència de Gestió d'Ajuts Universitaris i de Recerca
ID : 2017SGR1206
Pays : International
Organisme : Agència de Gestió d'Ajuts Universitaris i de Recerca
ID : SGR 2014SGR1430
Pays : International
Organisme : European Regional Development Fund
Pays : International
Organisme : European Social Fund
Pays : International

Informations de copyright

© 2020 International Society of Neuropathology.

Références

Am J Physiol Endocrinol Metab. 2009 Jan;296(1):E211-21
pubmed: 18854420
Acta Neuropathol. 2007 Dec;114(6):573-86
pubmed: 17828604
Blood. 2011 Aug 18;118(7):1971-8
pubmed: 21586746
Cell. 2019 May 30;177(6):1522-1535.e14
pubmed: 31130380
Immunity. 2017 May 16;46(5):730-742
pubmed: 28514674
FASEB J. 2008 Dec;22(12):4201-8
pubmed: 18757502
Cell Metab. 2008 Sep;8(3):224-36
pubmed: 18762023
Eur J Pharmacol. 2010 Oct 10;644(1-3):263-8
pubmed: 20655901
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14924-9
pubmed: 25267624
Nat Protoc. 2013 Jun;8(6):1149-54
pubmed: 23702831
PLoS One. 2014 Sep 25;9(9):e108655
pubmed: 25255441
J Lipid Res. 2010 Jan;51(1):162-8
pubmed: 19556607
Science. 2001 Mar 30;291(5513):2613-6
pubmed: 11283375
Acta Neuropathol. 2015 Mar;129(3):399-415
pubmed: 25549970
Eur J Biochem. 1997 Feb 15;244(1):1-14
pubmed: 9063439
Cell Metab. 2015 Apr 7;21(4):571-83
pubmed: 25817536
EMBO Mol Med. 2018 Aug;10(8):
pubmed: 29997171
Acta Neuropathol. 2017 Feb;133(2):283-301
pubmed: 28004277
J Biol Chem. 2013 Jun 28;288(26):19269-79
pubmed: 23671276
Mol Genet Metab. 2013 Nov;110(3):248-54
pubmed: 24075304
Biochemistry. 2018 Feb 06;57(5):827-838
pubmed: 29278326
Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9366-71
pubmed: 9256488
Biochem Biophys Res Commun. 2019 Jan 8;508(2):563-569
pubmed: 30509496
Hum Mol Genet. 2008 Jun 15;17(12):1762-73
pubmed: 18344354
Hum Mol Genet. 2004 Dec 1;13(23):2997-3006
pubmed: 15489218
Hum Mol Genet. 2015 Dec 15;24(24):6861-76
pubmed: 26370417
Hum Mol Genet. 2010 May 15;19(10):2005-14
pubmed: 20179078
Curr Biol. 2015 Jun 1;25(11):R470-81
pubmed: 26035793
Hum Mol Genet. 2002 Mar 1;11(5):499-505
pubmed: 11875044
Cell Death Differ. 2015 Nov;22(11):1742-53
pubmed: 25822341
J Neurochem. 1974 May;22(5):631-5
pubmed: 4407089
Cell Rep. 2013 May 30;3(5):1465-75
pubmed: 23684613
Neurobiol Dis. 2015 Dec;84:39-49
pubmed: 25796566
Methods Mol Biol. 2011;689:149-61
pubmed: 21153791
Mult Scler Relat Disord. 2015 Mar;4(2):159-69
pubmed: 25787192
J Lipid Res. 2000 Sep;41(9):1524-31
pubmed: 10974060
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
Am J Hum Genet. 2012 Dec 7;91(6):1073-81
pubmed: 23176823
Neurotherapeutics. 2019 Oct;16(4):1167-1182
pubmed: 31077039
Mol Genet Metab. 2017 Dec;122(4):145-152
pubmed: 29033250
Annu Rev Cell Dev Biol. 2017 Oct 6;33:491-510
pubmed: 28793795
Brain. 2013 Aug;136(Pt 8):2432-43
pubmed: 23794606
Mol Genet Metab. 2015 Jan;114(1):46-50
pubmed: 25481105
Science. 2009 Nov 6;326(5954):818-23
pubmed: 19892975
Brain. 2008 Jul;131(Pt 7):1722-35
pubmed: 18515320
Ann Neurol. 2011 Jul;70(1):84-92
pubmed: 21786300
Hum Mol Genet. 2012 Mar 1;21(5):1062-77
pubmed: 22095690
Brain. 2012 Dec;135(Pt 12):3584-98
pubmed: 23250880
JAMA Neurol. 2018 Oct 1;75(10):1175-1176
pubmed: 29946687
Fluids Barriers CNS. 2018 Apr 4;15(1):9
pubmed: 29615068
Annu Rev Nutr. 2015;35:321-48
pubmed: 26185979
Brain Res. 1988 Sep 1;471(1):131-8
pubmed: 2905927
Eur J Cell Biol. 1998 Mar;75(3):254-64
pubmed: 9587057
Dev Cell. 2018 May 21;45(4):427-432
pubmed: 29787708
Cell. 2015 Oct 8;163(2):340-53
pubmed: 26451484
Mol Genet Metab. 2011 Sep-Oct;104(1-2):27-34
pubmed: 21696988
Hum Mol Genet. 2013 Aug 15;22(16):3296-305
pubmed: 23604518
J Cell Biol. 2019 Aug 5;218(8):2583-2599
pubmed: 31227594
Biomed Pharmacother. 2006 May;60(4):182-5
pubmed: 16677798
Nat Rev Endocrinol. 2017 Dec;13(12):710-730
pubmed: 28849786
Brain. 2014 Mar;137(Pt 3):693-706
pubmed: 24480483
Metabolomics. 2016;12:91
pubmed: 27110228
J Nutr Biochem. 2014 Apr;25(4):475-82
pubmed: 24582286
Ann Neurol. 2006 Mar;59(3):478-89
pubmed: 16392116
Brain Pathol. 2010 Jul;20(4):817-30
pubmed: 20626743
Biochem J. 2008 Aug 1;413(3):369-87
pubmed: 18613815
Free Radic Biol Med. 2015 Nov;88(Pt A):18-29
pubmed: 26073123
Nature. 1993 Feb 25;361(6414):726-30
pubmed: 8441467
N Engl J Med. 2017 Oct 26;377(17):1630-1638
pubmed: 28976817
Antioxid Redox Signal. 2011 Oct 15;15(8):2095-107
pubmed: 21453200
Brain. 1998 Jul;121 ( Pt 7):1267-79
pubmed: 9679779
Cell Mol Life Sci. 2013 Mar;70(5):863-91
pubmed: 22869039
Orphanet J Rare Dis. 2012 Aug 13;7:51
pubmed: 22889154
Cell. 2015 Jan 15;160(1-2):177-90
pubmed: 25594180
Mult Scler. 2016 Nov;22(13):1719-1731
pubmed: 27589059
Hum Mol Genet. 2005 Dec 1;14(23):3565-77
pubmed: 16223892
Biochim Biophys Acta. 2012 Sep;1822(9):1475-88
pubmed: 22353463

Auteurs

Stéphane Fourcade (S)

Neurometabolic Diseases Laboratory, IDIBELL, Barcelona, Spain.
CIBERER U759, Center for Biomedical Research on Rare Diseases, Barcelona, Spain.

Leire Goicoechea (L)

Neurometabolic Diseases Laboratory, IDIBELL, Barcelona, Spain.
CIBERER U759, Center for Biomedical Research on Rare Diseases, Barcelona, Spain.

Janani Parameswaran (J)

Neurometabolic Diseases Laboratory, IDIBELL, Barcelona, Spain.
CIBERER U759, Center for Biomedical Research on Rare Diseases, Barcelona, Spain.

Agatha Schlüter (A)

Neurometabolic Diseases Laboratory, IDIBELL, Barcelona, Spain.
CIBERER U759, Center for Biomedical Research on Rare Diseases, Barcelona, Spain.

Nathalie Launay (N)

Neurometabolic Diseases Laboratory, IDIBELL, Barcelona, Spain.
CIBERER U759, Center for Biomedical Research on Rare Diseases, Barcelona, Spain.

Montserrat Ruiz (M)

Neurometabolic Diseases Laboratory, IDIBELL, Barcelona, Spain.
CIBERER U759, Center for Biomedical Research on Rare Diseases, Barcelona, Spain.

Alexandre Seyer (A)

Medday Pharmaceuticals SA, Paris, France.

Benoit Colsch (B)

Service de Pharmacologie et Immuno-Analyse (SPI), Laboratoire d'Etude du Métabolisme des Médicaments, CEA, INRA, Université Paris Saclay, MetaboHUB, Gif-sur-Yvette, F-91191, France.

Noel Ylagan Calingasan (NY)

Feil Family Brain and Mind Research Institute, Weill Cornell Medical College, New York, NY, 10065, USA.

Isidre Ferrer (I)

Department of Pathology and Experimental Therapeutics, IDIBELL, Faculty of Medicine, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, 08907, Spain.
Center for Biomedical Research on Neurodegenerative Diseases (CIBERNED), ISCIII, Madrid, Spain.
Institute of Neurosciences, University of Barcelona, Barcelona, Spain.

M Flint Beal (MF)

Feil Family Brain and Mind Research Institute, Weill Cornell Medical College, New York, NY, 10065, USA.

Frédéric Sedel (F)

Medday Pharmaceuticals SA, Paris, France.

Aurora Pujol (A)

Neurometabolic Diseases Laboratory, IDIBELL, Barcelona, Spain.
CIBERER U759, Center for Biomedical Research on Rare Diseases, Barcelona, Spain.
Catalan Institution of Research and Advanced Studies (ICREA), Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH